Data & Analytics
QuintilesIMS partners with Salesforce; the E.U. to decide on new EMA location by June; drugmakers boost lobbying dollars in Q1
This is likely due, in part, to the increasingly complex nature of new specialty drugs.
An analysis of claims data found that an off-label settlement for one Eli Lilly drug did not significantly change how often it was prescribed off-label after the settlements.
These facilities may be more prone to attack because there are more people at them with access to private patient data, whether to conduct medical research or educate new healthcare professionals.
In the wake of MD Anderson's costly failure with IBM's Watson supercomputer, a Watson backlash brewing in biopharma may lead to a moment of reckoning in life sciences.
Amy Molyneux is co-founder and EVP of Meta.
Libbe Englander is founder and CEO of Pharm3r.
Jeff Ceitlin is CCO of HVH Patient Precision Analytics.
Organizations are focusing on better ways to verify HCPs' digital identities.
Pfizer and Bristol-Myers Squibb were the top spenders last year.
Microsoft reenters healthcare market; Trump accuses Cummings of avoiding drug-pricing meeting; Trump says ACA replacement plan to be unveiled in March
Merck and Aetna partner in value-based drug pricing; data scientists rising in the biopharma ranks; Japanese pharma leads digital health innovation
Docs said patients asked about drugs from DTC ads six times in a typical week, compared to just twice a week five years ago.
How the retail pharmacy chain uses customer data to make its marketing messages relevant.
Deborah Furey will lead the agency's pilot of a new personalized marketing offering.
There are dozens of players, including leaders like IBM Watson Health and Verily as well as smaller concerns, lining up to sell pharma access to some sort of data solution.
Trump says pharma is "getting away with murder"; Senate majority votes to repeal ACA; IBM Watson Health and FDA to study blockchain technology
Data scientists are a new kind of insight and analytics professional showing up in the biopharma ranks.
The first step is to seek leadership support, she says.
Pharma can reach physicians within the EHR, but they must send the right message at the right time, she said at an MM&M event.
However, the rate of drug spending slowed compared to last year, according to an analysis by the CMS.
A new survey found that U.S. pharma marketers prefer using social media and mobile apps to reach healthcare providers.
Most physicians said EHRs have negatively impacted their communication with a patients.
The programmatic advertising technology company also hired Chris Neuner as SVP and GM of digital health.
BMS and Pfizer outspent Johnson & Johnson two-to-one in advertising for their oral anticoagulant last year.
Judges praised Wunderman Health and GSK for their agility in reacting to dynamic information and creating segment-specific messaging for nasal spray allergy treatment Flonase.
A tracking poll conducted by the Kaiser Family Foundation also found that fewer Americans are seeing prescription drug ads compared to last year.
Mayo Clinic's CEO talks about how a trusted name in healthcare has evolved digitally and centered communications on its newsroom while retaining integrity.
Physicians are seeking beyond-the-pill services from drugmakers; Novartis debunks misconception that only smokers get lung cancer; pharma's access to docs declines
Discovering Meaningful Insights in Patient Journeys: Identifying Hidden Patterns Using Advanced AnalyticsSeptember 21, 2016
During this seminar, attendees will learn how advanced data analytics can be applied to gain a measurable competitive advantage.
- Five things for pharma marketers to know: Monday, April 24, 2017
- Five things for pharma marketers to know: Friday, April 21, 2017
- Five things for pharma marketers to know: Tuesday, April 25, 2017
- Five things for pharma marketers to know: Wednesday, April 26, 2017
- Drugmakers battle for slice of Humira's billions
- How pharma marketers are using behavioral science
- Veeva and QuintilesIMS tussle over customer reference data
- Genentech urges broader adoption of value-based payment models
- Some brands thought to shift online ad dollars, creating uncertainty for WebMD
- Study: Medical-marijuana laws lower prescription drug usage